Riskpilot← Back to searchSign inGet full accessMedArctos AB
ABActiveOrg 5591932370Fagerövägen 30General medical practice activities · NACE 8621Est. 20191-4 employees
Revenue 2025
SEK 3,7M
-28% vs 2024
EBITDA margin
4.4%
-88% vs 2024
Equity ratio
43.3%
Financial strength
Net profit 2025
SEK 90K
-88% vs 2024
| Revenue | SEK 3,7M | -28% |
| EBITDA | SEK 163K | -88% |
| Net profit | SEK 90K | -88% |
| Total assets | SEK 1,2M | -30% |
| Equity | SEK 525K | -40% |
| Employees | — | — |
Legal name
MedArctos AB
Org number
5591932370
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
31 januari 2019
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-01-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bedriva utbildning och konsultverksamhet inom området hälso- och sjukvård till offentliga och privata aktörer. Bedriva allmänläkarmottagning och vaccinationsmottagning. Bedriva framställande och handel med text och bild för försäljning, utbildning och underhållning.
Address
Fagerövägen 30
Email
medarctos@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 109 | 1 746 | 4 239 | 5 180 | 3 717 |
| Staff expenses | — | — | −1 359 | −745 | −890 |
| EBITDA | 208 | 307 | 809 | 1 309 | 163 |
| Depreciation & amort. | −14 | −72 | −146 | −51 | −42 |
| EBIT | 194 | 235 | 663 | 1 258 | 121 |
| Net financials | −1 | — | −2 | −1 | −3 |
| Profit before tax | 194 | 235 | 475 | 941 | 118 |
| Tax | −42 | −49 | −98 | −196 | −28 |
| Net profit | 152 | 186 | 377 | 745 | 90 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 541 | 821 | 1 201 | 1 737 | 1 212 |
| Equity | 268 | 454 | 831 | 876 | 525 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 273 | 368 | 184 | 360 | 185 |
| Total debt | 273 | 368 | 184 | 360 | 185 |
EBITDA margin
4.4%
This company
15.8%
Market median
-72% vs market
20212025
Equity ratio
43.3%
This company
38.2%
Market median
+13% vs market
20212025
Return on equity
17.0%
This company
18.4%
Market median
+8% vs market
20212025
Net profit margin
2.4%
This company
8.1%
Market median
-70% vs market
20212025
Asset turnover
3.07×
This company
1.12×
Market median
+174% vs market
20212025
Debt / equity
1.31×
This company
0.62×
Market median
-111% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-02-01 – 2025-01-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-02-01 – 2024-01-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-02-01 – 2023-01-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-02-01 – 2022-01-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-02-01 – 2021-01-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
BE Chief Executive Officer | Chief Executive Officer | 2022 |
EK Audit | Audit | 2024 |
MY Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MedArctos AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Björn Erik Lindström | Chief Executive Officer | 0 companies |
| Emma Kristina Hed | Audit | 0 companies |
| Mikaela Youn Jin Näslund | Deputy Chief Executive Officer | 0 companies |